Abstract: Method for dosing fuel injected into an engine, with a fuel quantity for an injector, the fuel quantity being divided into pilot and main injections for respective activation duration having activation duration corrective value, the method may include storing correlation data between fuel injection quantity and activation time under at least a state parameter of the injector, wherein the fuel injection quantity includes reference total injection quantities determined for predetermined operating states of the engine, determining a present operating state of the engine, placing the engine into one of the predetermined operating states, determining a present total injection quantity and a reference total injection quantity in one of the at least a state parameter of the injector, and defining the respective activation duration corrective value for the pilot and main injection considering a difference between the reference total injection quantity and the present total injection quantity.

Abstract: Method for dosing fuel injected into an engine, with a fuel quantity for an injector, the fuel quantity being divided into pilot and main injections for respective activation duration having activation duration corrective value, the method may include storing correlation data between fuel injection quantity and activation time under at least a state parameter of the injector, wherein the fuel injection quantity includes reference total injection quantities determined for predetermined operating states of the engine, determining a present operating state of the engine, placing the engine into one of the predetermined operating states, determining a present total injection quantity and a reference total injection quantity in one of the at least a state parameter of the injector, and defining the respective activation duration corrective value for the pilot and main injection considering a difference between the reference total injection quantity and the present total injection quantity.

Abstract: The present invention relates to the use of an antisecretory protein or a derivative, homologue, and/or fragment thereof, having antisecretory activity, and/or a pharmaceutically active salt thereof, for the manufacture of a pharmaceutical composition and/or a medical food for the treatment and/or prevention of compartment syndrome. A compartment syndrome may be caused by or a cause of a variety of other conditions which are also encompassed by the present invention, such as viral and bacterial infections. Furthermore, the invention relates to a method for the treatment and/or prevention of compartment syndrome in a mammal in need thereof.

Abstract: The present invention relates to the use of antisecretory factors, such as antisecretory proteins, homologues, derivatives and/or fragments thereof having antisecretory activity, for the manufacture of a pharmaceutical composition for use in the treatment and/or prevention of intraocular hypertension. The invention thus relates to the use of pharmaceutical compositions comprising antisecretory factors in the treatment and/or prevention of intraocular hypertension, which is preferably characterized by hampered outflow of body fluid resulting in elevated pressure in the eye. The invention provides for a novel approach for treating and/or preventing such a condition turning the intraocular pressure to an acceptable level, optionally 21 mm Hg, or less.

Abstract: The present invention relates to the use of an antisecretory protein, derivative, homologue, and/or fragment thereof, having equivalent activity, and/or a pharmaceutically active salt thereof, for the manufacture of a pharmaceutical composition and/or a medical food for the treatment and/or prevention of dysfunction, e.g. abnormal function, hypo- or hyper-function of lipid rafts, receptors and/or caveolae. A dysfunction of lipid rafts, receptors and/or caveolae may be caused by or be a cause of a variety of other conditions, which are also encompassed by the present invention, such as vascular, and lung dysfunctions, and/or endocrine disorders, e.g. diabetes and related disorders. Furthermore, the invention relates to a method for the treatment and/or prevention of dysfunction of lipid rafts and/or caveolae in a mammal in need thereof.

Abstract: The use of products having enzymatic activity for the preparation of a food, including feed, inducing, when consumed, antisecretory proteins and the foods thus prepared. The products having enzymatic activity may for example be malted cereals.

Abstract: The invention relates to a system and a method for the treatment of a patient's eye. The system comprises a laser apparatus, a scanning apparatus and an eye tracking apparatus for determining the actual position of the patient's eye and for generating alignment data of the patient's eye relative to a reference position of the patient's eye to the laser, said eye tracking apparatus being provided with a desired treatment shot file. Said scanning apparatus is connected via a first bidirectional bus to the eye tracking apparatus, said laser apparatus is connected via a second bidirectional bus to the eye tracking apparatus. The eye tracking apparatus adjusts the position data for each shot based on said alignment data of the patient's eye and provides aiming control signals representative of the target position data to the scanning apparatus for said shot via said first bidirectional bus.

Abstract: The present invention is based on the concept to detect the noise which is generated when a laser pulse of the excimer laser hits on a reference material. In particular where the laser pulse of an excimer laser hits on a reference material the radiation ablates a corresponding volume of the reference material by photodecomposition. The ablated volume of material which is proportional to the pulse energy applied to the reference material can be determined based on measuring the acoustic shock wave resulting from the ablation. The reference material is preferably a plate made of a material erodable by an excimer laser, more preferably a plate made of plastics and most preferably PMMA.

Abstract: The invention relates to biotechnologically expressible, enzymically active recombinant porcine liver esterases, to a biotechnological method for the preparation thereof and to the use thereof in organic synthesis. The monomeric subunits of recombinant porcine liver esterase are truncated at their C-terminal end, compared with naturally occurring porcine liver esterase subunits. Moreover, it has proved to be an additional advantage to truncate the N-terminal end as well.

Abstract: The present invention relates to the use of an antisecretory protein or homologues thereof having the same properties, or certain fragments thereof in the manufacture of a medicament or a medical food for inducing improved rescue of injured or diseased nervous tissue, proliferation, apoptosis, differentiation and/or migration of an embryonic stem cell, adult stem cell, progenitor cell and/or a cell derived from a stem cell or progenitor cell, for treating a condition characterized by or associated with loss and/or gain of cells. In a preferred embodiment, the condition is a neurotrauma or a condition or disease of the CNS and/or PNS and/or ANS, for example, Alzheimer's disease.

Abstract: The invention generally relates to the use of natural anti-secretory protein (NASP) for the preparation of NASP-enriched functional food products or pharmaceutical products for the treatment and prophylaxis of disease-like conditions caused by extreme body fluid discharge. In particular, the invention relates to the use of NASP-enriched egg yolk as a source of NASP.

Abstract: The use of products having enzymatic activity for the preparation of a food, including feed, inducing, when consumed, antisecretory proteins and the foods thus prepared. The products having enzymatic activity may for example be malted cereals.

Abstract: A device readable medium for use in controlling a laser vision correction system includes a storage structure having stored therein a pre-programmed first, readable, corrective instruction reference that corresponds to an encoded customized corrective instruction determined by a calculation module external to the medium. The encoded customized corrective instruction is executable by a laser vision correction laser platform for correction of a refractive defect when the corrective instruction reference is properly recognized. A laser vision correction system including the device readable medium is described. A remunerative model relating to the device readable medium is disclosed.

Abstract: The invention relates to biotechnologically expressible, enzymically active recombinant porcine liver esterases, to a biotechnological method for the preparation thereof and to the use thereof in organic synthesis. The monomeric subunits of recombinant porcine liver esterase are truncated at their C-terminal end, compared with naturally occurring porcine liver esterase subunits. Moreover, it has proved to be an additional advantage to truncate the N-terminal end as well.

Abstract: A closing device for a vehicle door lock is actuated by a hand lever. The lock can be switched between a secured, inoperative position of the hand lever and an operative position in which the lock can be opened by the hand lever. An electric control device arranged within the vehicle effects via an antenna of a vehicle-correlated transmission and reception unit a data request directed to a data carrier external to the vehicle held by a vehicle user. The data carrier has a transmission and reception unit transmitting a data reply via the antenna of the vehicle-correlated transmission and reception unit to the control device which, for a positive identification of the data carrier, triggers securing, respectively, release of the lock. The antenna of the transmission and reception unit is arranged in the hand lever in addition to at least some further components of the transmission and reception unit.

Abstract: A device readable medium for use in controlling a laser vision correction system includes a storage structure having stored therein a pre-programmed first, readable, corrective instruction reference that corresponds to an encoded customized corrective instruction determined by a calculation module external to the medium. The encoded customized corrective instruction is executable by a laser vision correction laser platform for correction of a refractive defect when the corrective instruction reference is properly recognized. A laser vision correction system including the device readable medium is described. A remunerative model relating to the device readable medium is disclosed.

Abstract: Data management systems of real-time systems are intended to provide user systems with rapid and consistent on-line management of various data generations. This is achieved by an access data structure which allows a generations management system (GMS) to carry out the management of various data generations on the basis of the same data objects already used on a previous occasion by a transaction management system (TMS) for carrying out transactions.

Abstract: The invention generally relates to the use of natural anti-secretory proteins (NASP) for the preparation of NASP-enriched functional food products or pharmaceutical products for the treatment and prophylaxis of disease-like conditions caused by extreme body fluid discharge. In particular, the invention relates to the use of NASP-enriched egg yolk as source of NASP.

Abstract: The invention generally relates to the use of natural anti-secretory protein (NASP) for the preparation of NASP-enriched functional food products or pharmaceutical products for the treatment and prophylaxis of disease-like conditions caused by extreme body fluid discharge. In particular, the invention relates to the use of NASP-enriched egg yolk as a source of NASP.